Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening

被引:80
作者
Chuaqui, C [1 ]
Deng, Z [1 ]
Singh, J [1 ]
机构
[1] Biogen Idec Inc, Dept Res Informat, Computat Drug Design Grp, Cambridge Ctr 14, Cambridge, MA 02142 USA
关键词
D O I
10.1021/jm049312t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A major challenge facing structure-based drug discovery efforts is how to leverage the massive amount of experimental (X-ray and NMR) and virtual structural information generated from drug discovery projects. Many important drug targets have large numbers of protein-inhibitor complexes, necessitating tools to compare and contrast their similarities and differences. ThiS information would be valuable for understanding potency and selectivity of inhibitors and could be used to define target constraints to assist virtual screening. We describe a profile-based approach that enables us to capture the conservation of interactions between a set, of protein ligand receptor complexes. The use of profiles provides a sensitive means to compare multiple inhibitors binding to a drug target. We demonstrate the utility of profile-based analysis of small molecule complexes from the protein-kinase family to identify, similarities and differences in binding of ATP, p38, and CDK2 compounds to kinases and how these profiles can be applied to differentiate the selectivity of these inhibitors. Importantly.. our virtual screening results demonstrate superior enrichment of kinase inhibitors using profile-based methods relative to traditional scoring functions. Interaction-based analysis should provide a valuable tool for understanding inhibitor binding to other important drug targets.
引用
收藏
页码:121 / 133
页数:13
相关论文
共 60 条
[41]   Recovering the true targets of specific ligands by virtual screening of the Protein Data Bank [J].
Paul, N ;
Kellenberger, E ;
Bret, G ;
Müller, P ;
Rognan, D .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 54 (04) :671-680
[42]   A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance [J].
Perola, E ;
Walters, WP ;
Charifson, PS .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2004, 56 (02) :235-249
[43]   A fast flexible docking method using an incremental construction algorithm [J].
Rarey, M ;
Kramer, B ;
Lengauer, T ;
Klebe, G .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 261 (03) :470-489
[44]   Comparison of chemical clustering methods using graph- and fingerprint-based similarity measures [J].
Raymond, JW ;
Blankley, CJ ;
Willett, P .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2003, 21 (05) :421-433
[45]   A 3D-1D substitution matrix for protein fold recognition that includes predicted secondary structure of the sequence [J].
Rice, DW ;
Eisenberg, D .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 267 (04) :1026-1038
[46]   Structural biology in drug design: selective protein kinase inhibitors [J].
Scapin, G .
DRUG DISCOVERY TODAY, 2002, 7 (11) :601-611
[47]   Binding site characteristics in structure-based virtual screening: evaluation of current docking tools [J].
Schulz-Gasch, T ;
Stahl, M .
JOURNAL OF MOLECULAR MODELING, 2003, 9 (01) :47-57
[48]  
*SCIT INC, PIP PIL
[49]   Successful shape-based virtual screening:: The discovery of a potent inhibitor of the type I TGFβ receptor kinase (TβRI) [J].
Singh, J ;
Chuaqui, CE ;
Boriack-Sjodin, PA ;
Lee, WC ;
Pontz, T ;
Corbley, MJ ;
Cheung, HK ;
Arduini, RM ;
Mead, JN ;
Newman, MN ;
Papadatos, JL ;
Bowes, S ;
Josiah, S ;
Ling, LE .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (24) :4355-4359
[50]   Detailed analysis of scoring functions for virtual screening [J].
Stahl, M ;
Rarey, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (07) :1035-1042